article thumbnail

Nigerian e-health pharmaceutical distribution startup DrugStoc secures $4.4 million Series A funding, embarks on expansion drive

TechCrunch

The pharmaceutical supply chain across Africa has for decades remained fragmented leading to sourcing and distribution challenges as well as quality concerns; as fake and substandard products flood the market. Chibuzo Opara and Adham Yehia, the co-founders of DrugStoc, a tech-based pharmaceutical procurement platform.

article thumbnail

Balancing Innovation and Safety: The Tepezza Lawsuit’s Implications for the Pharmaceutical Industry

Strategy Driven

The mere onset of an unknown medical condition has the pharmaceutical giants leaving no stone unturned to deliver the antidotes as fast as they can. In this blog post, we will shed light on the concerns surrounding Tepezza and what it means for the ever-growing pharmaceutical industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Key Pharmaceutical Use Cases for Embracing AI

Dataiku

According to a survey of 1,200 global companies sponsored by Dataiku in September 2020, 66% of life sciences or pharmaceutical organizations believe AI is either considerably or very important to the future of their business. This goes to show the immense potential that AI and machine learning have in the pharmaceutical industry.

article thumbnail

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

TechCrunch

Other heavy hitters in the world of medicine and biotechnology who are working with the company include Frances Arnold, the Nobel Prize-winning professor from the California Institute of Technology; George Barrett, the former chief executive of Cardinal Health; Susan Desmond-Hellmann, the former president of product development at Genentech; Kaye Foster, (..)

article thumbnail

Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

TechCrunch

Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion.

article thumbnail

How Pharmaceutical Companies Can Continuously Generate Market Impact With AI

Dataiku

These are massive numbers and, while true that research and discovery are a key part of the life sciences and pharmaceuticals value chain, data science, machine learning, and AI can play a valuable role across its entirety. Total spending on AI-related drug discovery and development tools is expected to hit $1.3

article thumbnail

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

TechCrunch

The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. Register here. It’s free to watch and participate.